Sarepta Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sarepta Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Sarepta Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $43.5M, a 9.56% decline year-over-year.
  • Sarepta Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $180M, a 3.68% decline year-over-year.
  • Sarepta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $183M, a 21.7% decline from 2022.
  • Sarepta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $233M, a 105% increase from 2021.
  • Sarepta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $114M, a 5.43% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $180M $43.5M -$4.6M -9.56% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $185M $50.5M +$3.1M +6.54% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $182M $40.7M -$600K -1.45% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $183M $45.7M -$4.8M -9.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $187M $48.1M -$2.32M -4.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $190M $47.4M -$55.5M -53.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $245M $41.3M +$12.1M +41.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $233M $50.5M +$20.7M +69.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $212M $50.4M +$23.7M +88.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $189M $103M +$73.9M +255% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $115M $29.2M +$690K +2.42% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $114M $29.8M +$255K +0.86% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $114M $26.7M -$219K -0.81% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $114M $29M +$1.35M +4.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $113M $28.5M +$4.48M +18.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $108M $29.5M +$7.46M +33.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $101M $26.9M +$6.27M +30.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $94.3M $27.6M +$7.85M +39.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $86.5M $24M +$7.89M +48.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $78.6M $22.1M +$9.23M +71.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $69.4M $20.6M +$9.15M +79.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $60.2M $19.8M +$4.48M +29.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $55.7M $16.1M +$5.61M +53.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $50.1M $12.8M +$5.47M +74.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $44.7M $11.5M +$4.56M +65.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $40.1M $15.3M +$4.81M +46% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $35.3M $10.5M +$4.81M +84.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $30.5M $7.37M +$497K +7.24% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $30M $6.92M -$2.65M -27.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $32.6M $10.5M +$3.64M +53.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $29M $5.71M -$978K -14.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $30M $6.87M +$521K +8.21% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $29.4M $9.57M +$3.89M +68.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $25.6M $6.83M +$900K +15.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $24.7M $6.69M -$7.47M -52.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $32.1M $6.35M +$581K +10.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $31.5M $5.68M +$1.03M +22.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $30.5M $5.93M +$343K +6.14% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $30.2M $14.2M +$9.81M +226% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $20.3M $5.77M +$2.12M +58% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $18.2M $4.65M +$1.16M +33.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $17.1M $5.59M +$3.27M +141% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $13.8M $4.34M +$2.67M +160% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $11.1M $3.65M +$2.41M +195% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-25
Q3 2013 $8.71M $3.49M +$2.8M +404% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $5.92M $2.32M +$1.88M +427% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $4.04M $1.67M +$963K +136% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $3.08M $1.24M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 $692K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $440K -$152K -25.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $708K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q2 2011 $592K Apr 1, 2011 Jun 30, 2011 10-Q 2012-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.